Medical Condition News

RSS

CEL-SCI announces results from Multikine Phase II trial on head and neck cancer

CEL-SCI Corporation announced today data from its Phase II clinical studies which showed that its lead drug Multikine was able to lower cholesterol in studies involving 120 head and neck cancer patients.

22 Jun 2011

Frankincense may help treat painful arthritis

The answer to treating painful arthritis could lie in an age old herbal remedy - frankincense, according to Cardiff University scientists.

22 Jun 2011

Frequent nighttime home dialysis more effective for patients with kidney failure

Researchers at St. Michael's Hospital have found more evidence of the benefits of home dialysis for patients with kidney failure.

22 Jun 2011

Reduced levels of VAPB protein may play central role in causing ALS

An international team of scientists led by researchers at the University of California, San Diego School of Medicine have used induced pluripotent stem cells (iPSCs) derived from patients with amyotrophic lateral sclerosis (ALS) to reveal for the first time how reduced levels of a specific protein may play a central role in causing at least one inherited form of the disease.

22 Jun 2011

Exercise helps overcome side effects of cancer, improves survival

Brain cancer patients who are able to exercise live significantly longer than sedentary patients, scientists at the Duke Cancer Institute report.

22 Jun 2011

Blueberry compounds might aid in building strong bones

Compounds in blueberries might turn out to have a powerful effect on formation of strong, healthy bones, if results from studies with laboratory rats turn out to hold true for humans.

22 Jun 2011

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Pfizer Inc. announced today that top-line results for Lyrica Study A0081107 - Central Neuropathic Pain Following Spinal Cord Injury - demonstrated that the study met its primary endpoint: positive efficacy in reducing Central Neuropathic Pain following Spinal Cord Injury with Lyrica compared to placebo.

22 Jun 2011

Research focuses on how marijuana affects decision-making process

Smoking marijuana affects peoples' impulsivity, attention, memory, cognition and decision-making abilities. That's been scientifically proven.

22 Jun 2011

Experts to discuss science and clinical management of vasospasm at Cincinnati conference

Cerebrovascular experts from around the world will gather in Cincinnati next month to discuss the science and clinical management of vasospasm, a dreaded, life-threatening complication of subarachnoid hemorrhage, while working toward an ambitious goal.

22 Jun 2011

Smoking may increase risk of death from prostate cancer

Men who are diagnosed with prostate cancer and who are also smokers have an associated increased risk of all-cause, cardiovascular and prostate cancer-specific death, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

UAB Cancer Care Network brings specialized care close to patient's homes

Often people diagnosed with cancer who don't live near a major academic medical center have limited choices for specialized cancer care close to home. The University of Alabama at Birmingham Comprehensive Cancer Center and UAB Medicine developed the UAB Cancer Care Network to bring leading-edge care to these communities, giving patients an opportunity to stay close to home while giving doctors and nurses access to leading cancer research.

22 Jun 2011

Avedro receives Gold MDEA award for Vedera System

Avedro, Inc. announced today that the Vedera System for performing Keraflex has received the prestigious Gold level 2011 Medical Design Excellence Award.

22 Jun 2011

International representatives discuss whether to add chrysotile asbestos to hazardous chemical treaty

On Monday, representatives from 143 countries met in Geneva to discuss whether chrysotile asbestos "should be added to an international treaty regulating the trade in hazardous chemicals," CBC Radio reports.

22 Jun 2011

Scientists discover molecular mechanism that could help develop new MS treatments

Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.

22 Jun 2011

New-onset diabetes risk increases with intensive-dose statin therapy

An analysis of data from previously published studies indicates that intensive-dose statin therapy is associated with an increased risk of new-onset diabetes compared with moderate-dose therapy, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Study finds high prevalence of diabetic kidney disease in the U.S.

Over the past 2 decades the prevalence of diabetic kidney disease in the U.S. increased in direct proportion to the prevalence of diabetes itself, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

Tips for protecting your skin from sun's harmful rays

Summer is here and for many that means enjoying more outdoor activities. While it's important to remember sun safety, from time-to-time sunburns are bound to happen. Covenant Health System would like to promote sun safety and offer some useful remedies for dealing with sunburns.

22 Jun 2011

Novel method of disguising nanoparticles as red blood cells to fight cancer

Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body's immune system and deliver cancer-fighting drugs straight to a tumor. Their research was published this week in the online Early Edition of the Proceedings of the National Academy of Sciences.

22 Jun 2011

New VEP technique fast and effective for detecting glaucoma damage

A recent paper published in the Journal of Glaucoma shows a new visual evoked potential (VEP) technique to be a fast, objective method to screen for functional damage in glaucomatous eyes.

22 Jun 2011

Caffeinated coffee boosts blood GCSF levels, protects against Alzheimer's

A yet unidentified component of coffee interacts with the beverage's caffeine, which could be a surprising reason why daily coffee intake protects against Alzheimer's disease.

22 Jun 2011